Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Article
  • Cited by 35
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Cardoso, Fatima Spence, Danielle Mertz, Shirley Corneliussen-James, Dian Sabelko, Kimberly Gralow, Julie Cardoso, Maria-João Peccatori, Fedro Paonessa, Diego Benares, Ann Sakurai, Naomi Beishon, Marc Barker, Sarah-Jane and Mayer, Musa 2018. Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015). The Breast, Vol. 39, Issue. , p. 131.
    Williamson, Timothy J. Love, Susan M. Clague DeHart, Jessica N. Jorge-Miller, Alexandra Eshraghi, Leah Cooper Ortner, Heather and Stanton, Annette L. 2018. Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE). Breast Cancer Research and Treatment,
    Di Lascio, Simona and Pagani, Olivia 2017. Is it time to address survivorship in advanced breast cancer? A review article. The Breast, Vol. 31, Issue. , p. 167.
    Jacob, Louis Kalder, Matthias and Kostev, Karel 2017. Incidence of depression and anxiety among women newly diagnosed with breast or genital organ cancer in Germany. Psycho-Oncology, Vol. 26, Issue. 10, p. 1535.
    Caruso, R. Nanni, M. G. Riba, M. Sabato, S. Mitchell, A. J. Croce, E. and Grassi, L. 2017. Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncologica, Vol. 56, Issue. 2, p. 146.
    Hofmann, Sonja Hess, Stephanie Klein, Carsten Lindena, Gabriele Radbruch, Lukas Ostgathe, Christoph and Yuan, Tifei 2017. Patients in palliative care—Development of a predictive model for anxiety using routine data. PLOS ONE, Vol. 12, Issue. 8, p. e0179415.
    Kinslow, Connor J. Rajpara, Raj S. Wu, Cheng-Chia Bruce, Samuel S. Canoll, Peter D. Wang, Shih-Hsiu Sonabend, Adam M. Sheth, Sameer A. McKhann, Guy M. Sisti, Michael B. Bruce, Jeffrey N. and Wang, Tony J. C. 2017. Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system. Journal of Neuro-Oncology, Vol. 133, Issue. 2, p. 409.
    Shin, Jennifer A. El-Jawahri, Areej Parkes, Amanda Schleicher, Stephen M. Knight, Helen P. and Temel, Jennifer S. 2016. Quality of Life, Mood, and Prognostic Understanding in Patients with Metastatic Breast Cancer. Journal of Palliative Medicine, Vol. 19, Issue. 8, p. 863.
    Sakaguchi, Satoko and Okamura, Hitoshi 2015. Effectiveness of collage activity based on a life review in elderly cancer patients: A preliminary study. Palliative and Supportive Care, Vol. 13, Issue. 02, p. 285.
    Miladinovic, Tanya Nashed, Mina and Singh, Gurmit 2015. Overview of Glutamatergic Dysregulation in Central Pathologies. Biomolecules, Vol. 5, Issue. 4, p. 3112.
    Hansen, Melissa V. Andersen, Lærke T. Madsen, Michael T. Hageman, Ida Rasmussen, Lars S. Bokmand, Susanne Rosenberg, Jacob and Gögenur, Ismail 2014. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Breast Cancer Research and Treatment, Vol. 145, Issue. 3, p. 683.
    Taylor-Ford, Megan 2014. Clinical Considerations for Working with Patients with Advanced Cancer. Journal of Clinical Psychology in Medical Settings, Vol. 21, Issue. 3, p. 201.
    Krigel, Susan Myers, Jamie Befort, Christie Krebill, Hope and Klemp, Jennifer 2014. ‘Cancer changes everything!’ Exploring the lived experiences of women with metastatic breast cancer. International Journal of Palliative Nursing, Vol. 20, Issue. 7, p. 334.
    Lôbo, Sâmya Aguiar Fernandes, Ana Fátima Carvalho Almeida, Paulo César de Carvalho, Carolina Maria de Lima and Sawada, Namie Okino 2014. Qualidade de vida em mulheres com neoplasias de mama em quimioterapia. Acta Paulista de Enfermagem, Vol. 27, Issue. 6, p. 554.
    Tan, Jason D. Butow, Phyllis N. Boyle, Frances M. Saw, Robyn P.M. and O’Reilly, Amanda J. 2014. A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers. Melanoma Research, Vol. 24, Issue. 3, p. 252.
    Lazar, Susan G. 2014. The Cost-Effectiveness of Psychotherapy for the Major Psychiatric Diagnoses. Psychodynamic Psychiatry, Vol. 42, Issue. 3, p. 423.
    McDougall, Graham J. Oliver, JoAnn S. and Scogin, Forrest 2014. Memory and Cancer: A Review of the Literature. Archives of Psychiatric Nursing, Vol. 28, Issue. 3, p. 180.
    Lam, W. W. T. Soong, I. Yau, T. K. Wong, K. Y. Tsang, J. Yeo, W. Suen, J. Ho, W. M. Sze, W. K. Ng, A. W. Y. Kwong, A. Suen, D. and Fielding, R. 2013. The evolution of psychological distress trajectories in women diagnosed with advanced breast cancer: a longitudinal study. Psycho-Oncology, Vol. 22, Issue. 12, p. 2831.
    Thompson, Elizabeth Stanton, Annette L. and Bower, Julienne E. 2013. Situational and Dispositional Goal Adjustment in the Context of Metastatic Cancer. Journal of Personality, Vol. 81, Issue. 5, p. 441.
    Mosher, Catherine E. Johnson, Courtney Dickler, Maura Norton, Larry Massie, Mary Jane and DuHamel, Katherine 2013. Living with Metastatic Breast Cancer: A Qualitative Analysis of Physical, Psychological, and Social Sequelae. The Breast Journal, Vol. 19, Issue. 3, p. 285.
    Download full list
    ×
  • Get access
    Add to cart USD35.00
    Check if you have access via personal or institutional login
    Log in Register Recommend to librarian

Depression in women with metastatic breast cancer: A review of the literature

  • Aude Caplette-Gingras (a1) (a2) and Josée Savard (a1) (a2)
Abstract
Objective:

The aim of this article is to review the available literature on depression in women with metastatic breast cancer in terms of prevalence, potential risk factors, and consequences, as well as pharmacological and psychological interventions.

Method:

An extensive review of the literature was conducted.

Results:

The prevalence of depression appears to be especially elevated in patients with advanced cancer. Many demographic, medical, and psychosocial factors may increase the risk that women will develop depressive symptoms during the course of their illness. Despite the fact that depression appears to be associated with numerous negative consequences, this disorder remains underdiagnosed and undertreated. Both pharmacotherapy and psychotherapy have been found to treat effectively depressive symptoms in this population, but cognitive-behavioral therapy appears to be the most cost-effective approach.

Significance of results:

Areas for future research are suggested.

Copyright
COPYRIGHT: © Cambridge University Press 2008
Corresponding author
Address correspondence and reprint requests to: Josée Savard, Laval University Cancer Research Center, 11 Côte du Palais, Québec, Québec, G1R 2J6, Canada. E-mail: josee.savard@psy.ulaval.ca
References
Hide All
Aaronson, N.K., Ahmedzai, S., Bergman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Association.
Antoni, M.H., Lehman, J.M., Kilbourn, K.M., et al. (2001). Cognitive–behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20, 20–32.
Aragona, M., Muscatello, M.R.A., Losi, E., et al. (1996). Lymphocyte number and stress parameter modifications in untreated breast cancer patients with depressive mood and previous life stress. Journal of Experimental Therapeutics and Oncology, 1, 354–360.
Arathuzik, D. (1994). Effects of cognitive–behavioral strategies on pain in cancer patients. Cancer Nursing, 17, 207–214.
Badger, T.A., Braden, C.J., Mishel, M.H., et al. (2004). Depression burden, psychological adjustment, and quality of life in women with breast cancer: Patterns over time. Research in Nursing and Health, 27, 19–28.
Beck, A.T., Rush, A.J., Shaw, B.F., et al. (1979). Cognitive Therapy of Depression. New York: The Guilford Press.
Beck, A.T., Ward, C.E., Mendelson, M., et al. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.
Bender, C.M., Ergyn, F.S., Rosenzweig, M.Q., et al. (2005). Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nursing, 28, 219–225.
Björkenstam, C., Edberg, A., Ayoubi, S., et al. (2005). Are cancer patients at higher suicide risk than the general population? Scandinavian Journal of Public Health, 33, 208–214.
Block, S.D. (2000). Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians—American Society of Internal Medicine. Annals of Internal Medicine, 132, 209–218.
Bowers, L. & Boyle, D.A. (2003). Depression in patients with advanced cancer. Clinical Journal of Oncology Nursing, 7, 281–288.
Breitbart, W., Rosenfeld, B., Pessin, H., et al. (2000). Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA, 284, 2907–2911.
Brown, C., Battista, D.R., Bruehlman, R., et al. (2005). Beliefs about antidepressant medications in primary care patients: Relationship to self-reported adherence. Medical Care, 43, 1203–1207.
Butler, L.D., Koopman, C., Cordova, M.J., et al. (2003). Psychological distress and pain significantly increase before death in metastatic breast cancer patients. Psychosomatic Medicine, 65, 416–426.
Byar, K.L., Berger, A.M., Bakken, S.L., et al. (2006). Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncology Nursing Forum, 33, E18–26.
Carpenter, J.S., Elam, J., Ridner, S., et al. (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncology Nursing Forum, 31, 591–598.
Chambless, D.L. & Ollendick, T.H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716.
Chochinov, H.M., Wilson, K.G., Enns, M., et al. (1995). Desire for death in the terminally ill. American Journal of Psychiatry, 152, 1185–1191.
Ciaramella, A. & Poli, P. (2001). Assessment of depression among cancer patients: The role of pain, cancer type and treatment. Psycho-oncology, 10, 156–165.
Classen, C., Butler, L.D., Koopman, C., et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer. Archives of General Psychiatry, 58, 494–501.
Dunkel-Schetter, C., Feinstein, L.G., Taylor, S.E., et al. (1992). Patterns of coping with cancer. Health Psychology, 11, 79–87.
Edelman, S., Bell, D.R. & Kidman, A.D. (1999 a). A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-oncology, 8, 295–305.
Edelman, S., Lemon, J., Bell, D.R., et al. (1999 b). Effects of group CBT on the survival time of patients with metastatic breast cancer. Psycho-oncology, 8, 474–481.
Edmonds, C.V.I., Lockwood, G.A. & Cunningham, A.J. (1999). Psychological response to long term group therapy: A randomized trial with metastatic breast cancer patients. Psycho-oncology, 8, 74–91.
Filiberti, A., Ripamonti, C., Totis, A., et al. (2001). Characteristics of terminal cancer patients who committed suicide during a home palliative care program. Journal of Pain and Symptom Management, 22, 544–553.
Fisch, M. (2004). Treatment of depression in cancer. Journal of the National Cancer Institute Monographs, 105–111.
Fisch, M.J., Loehrer, P.J., Kristeller, J., et al. (2003). Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology Group. Journal of Clinical Oncology, 21, 1937–1943.
Fulton, C. (1998). The prevalence and detection of psychiatric morbidity in patients with metastatic breast cancer. European Journal of Cancer Care, 7, 232–239.
Fulton, C.L. (1997). The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. European Journal of Cancer Care, 6, 262–266.
Given, C., Given, B., Rahbar, M., et al. (2004). Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. Journal of Clinical Oncology, 22, 507–516.
Goodwin, J.S., Zhang, D.D. & Ostir, G.V. (2004). Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. Journal of the American Geriatrics Society, 52, 106–111.
Goodwin, P., Leszcz, M., Ennis, M., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine, 345, 1719–1726.
Greenberg, D.B. (2004). Barriers to the treatment of depression in cancer patients. Journal of the National Cancer Institute Monographs, 127–135.
Hamilton, M.A. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–61.
Hirai, K., Suzuki, Y., Tsuneto, S., et al. (2002). A structural model of the relationships among self-efficacy, psychological adjustment, and physical condition in Japanese advanced cancer patients. Psycho-oncology, 11, 221–229.
Holland, J.C., Romano, S.J., Heiligenstein, J.H., et al. (1998). A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-oncology, 7, 291–300.
Hopwood, P., Howell, A. & Maguire, P. (1991 a). Psychiatric morbidity in patients with advanced cancer of the breast: Prevalence measured by two self-rating questionnaires. British Journal of Cancer, 64, 349–352.
Hopwood, P., Howell, A. & Maguire, P. (1991 b). Screening for psychiatric morbidity in patients with advanced breast cancer: Validation of two self-report questionnaires. British Journal of Cancer, 64, 353–356.
Hotopf, M., Chidgey, J., Addington-Hall, J., et al. (2002). Depression in advanced disease: A systematic review, Part 1. Prevalence and case finding. Palliative Medicine, 16, 81–97.
Kathol, R.G., Mutgi, A., Williams, J., et al. (1990). Diagnosis of major depression in cancer patients according to four sets of criteria. American Journal of Psychiatry, 147, 1021–1024.
Kelly, B., Burnett, P., Pelusi, D., et al. (2003). Factors associated with the wish to hasten death: A study of patients with terminal illness. Psychological Medicine, 33, 75–81.
Kessler, R.C., McGonagle, K.A., Zhao, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
Kissane, D.W., Clarke, D.M., Ikin, J., et al. (1998). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: A cross-sectional survey. Medical Journal of Australia, 169, 192–196.
Kissane, D.W., Grabsch, B., Love, A., et al. (2004). Psychiatric disorder in women with early stage and advanced breast cancer: A comparative analysis. Australian and New Zealand Journal of Psychiatry, 38, 320–326.
Koopman, C., Nouriani, B., Erickson, V., et al. (2002). Sleep disturbances in women with metastatic breast cancer. Breast Journal, 8, 362–370.
Kugaya, A., Akechi, T., Nakano, T., et al. (1999). Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death. Supportive Care in Cancer, 7, 432–436.
Ladd, C.O., Newport, D.J., Ragan, K.A., et al. (2005). Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depression and Anxiety, 22, 94–97.
Lévesque, M., Savard, J., Simard, S., et al. (2004). Efficacy of cognitive therapy for depression among women with metastatic cancer: A single-case experimental study. Journal of Behavior Therapy and Experimental Psychiatry, 35, 287–305.
Lloyd-Williams, M., Dennis, M. & Taylor, F. (2004). A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliative Medicine, 18, 558–563.
Love, A.W., Grabsch, B., Clarke, D.M., et al. (2004). Screening for depression in women with metastatic breast cancer: A comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Australian and New Zealand Journal of Psychiatry, 38, 526–531.
Marchioro, G., Azzarello, G., Checchin, F., et al. (1996). The impact of a psychological intervention on quality of life in non-metastatic breast cancer. European Journal of Cancer, 32A, 1612–1615.
Massie, M.J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs, 57–71.
Massie, M.J., Gagnon, P. & Holland, J.C. (1994). Depression and suicide in patients with cancer. Journal of Pain and Symptom Management, 9, 325–340.
McNair, D.M., Lorr, M. & Droppleman, L.F. (1971). Edits Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
Meyer, H.A., Sinnott, C. & Seed, P.T. (2003). Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliative Medicine, 17, 604–607.
Miranda, C.R., de Resende, C.N., Melo, C.F., et al. (2002). Depression before and after uterine cervix and breast cancer neoadjuvant chemotherapy. International Journal of Gynecological Cancer, 12, 773–776.
Morrow, G.R., Hickok, J.T., Roscoe, J.A., et al. (2003). Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology program. Journal of Clinical Oncology, 21, 4635–4641.
Musselman, D.L., Lawson, D.H., Gumnick, J.F., et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine, 344, 961–966.
Mystakidou, K., Rosenfeld, B., Parpa, E., et al. (2005 a). Desire for death near the end of life: The role of depression, anxiety and pain. General Hospital Psychiatry, 27, 258–262.
Mystakidou, K., Tsilika, E., Parpa, E., et al. (2005 b). Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Quality of Life Research, 14, 1825–1833.
O'Brien, A.R. (2003). The impact of physical activity on quality of life, depression, and anxiety in breast cancer patients undergoing treatment. Dissertation Abstracts International, 65(5-B), 2397.
Okamura, M., Yamawaki, S., Akechi, T., et al. (2005). Psychiatric disorders following first breast cancer recurrence: Prevalence, associated factors and relationship to quality of life. Japanese Journal of Clinical Oncology, 35, 302–309.
O'Mahony, S., Goulet, J., Kornblith, A., et al. (2005). Desire for hastened death, cancer pain and depression: Report of a longitudinal observational study. Journal of Pain and Symptom Management, 29, 446–457.
Palesh, O.G., Collie, K., Batiuchok, D., et al. (2007). A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biological Psychology, 75, 37–44.
Parker, P.A., Baile, W.F., de Moor, C., et al. (2003). Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psycho-oncology, 12, 183–193.
Pasacreta, J.V. (1997). Depressive phenomena, physical symptom distress, and functional status among women with breast cancer. Nursing Research, 46, 214–221.
Pettingale, K.W., Burgess, C. & Greer, S. (1988). Psychological response to cancer diagnosis—I. Correlations with prognostic variables. Journal of Psychosomatic Research, 32, 255–261.
Pinder, K.L., Ramirez, A.J., Black, M.E., et al. (1993). Psychiatric disorder in patients with advanced breast cancer: Prevalence and associated factors. European Journal of Cancer, 29A, 524–527.
Plumb, M. & Holland, J. (1981). Comparative studies of psychological function in patients with advanced cancer II. Interviewer-rated current and past psychological symptoms. Psychosomatic Medicine, 43, 243–254.
Potash, M. & Breitbart, W. (2002). Affective disorders in advanced cancer. Hematology/Oncology Clinics of North America, 16, 671–700.
Ranchor, A.V., Sanderman, R., Steptoe, A., et al. (2002). Pre-morbid predictors of psychological adjustment to cancer. Quality of Life Research, 11, 101–113.
Razavi, D., Allilaire, J.F., Smith, M., et al. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica, 94, 205–210.
Reiche, E.M., Nunes, S.O. & Morimoto, H.K. (2004). Stress, depression, the immune system, and cancer. Lancet Oncology, 5, 617–625.
Reuter, K., Classen, C.C., Roscoe, J.A., et al. (2006). Association of coping style, pain, age and depression with fatigue in women with primary breast cancer. Psycho-oncology, 15, 772–779.
Roscoe, J.A., Morrow, G.R., Hickok, J.T., et al. (2005). Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment, 89, 243–249.
Rustøen, T., Moum, T., Padilla, G., et al. (2005). Predictors of quality of life in oncology outpatients with pain from bone metastasis. Journal of Pain and Symptom Management, 30, 234–242.
Sachs, G., Rasoul-Rockenschaub, S., Aschauer, H., et al. (1995). Lytic effector cell activity and major depressive disorder in patients with breast cancer: A prospective study. Journal of Neuroimmunology, 59, 83–89.
Savard, J., Simard, S., Giguere, I., et al. (2006). Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects. Palliative & Supportive Care, 4, 219–237.
Schnoll, R.A., Harlow, L.L., Stolbach, L.L., et al. (1998). A structural model of the relationships among stage of disease, age, coping, and psychological adjustment in women with breast cancer. Psycho-oncology, 7, 69–77.
Shapiro, S.L., Lopez, A.M., Schwartz, G.E., et al. (2001). Quality of life and breast cancer: Relationship to psychosocial variables. Journal of Clinical Psychology, 57, 501–519.
Sharpe, M., Strong, V., Allen, K., et al. (2004). Major depression in outpatients attending a regional cancer centre: Screening and unmet treatment needs. British Journal of Cancer, 90, 314–320.
Skarstein, J., Aass, N., Fossa, S.D., et al. (2000). Anxiety and depression in cancer patients: Relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. Journal of Psychosomatic Research, 49, 27–34.
Smith, E.M., Gomm, S.A. & Dickens, C.M. (2003). Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliative Medicine, 17, 509–513.
Spiegel, D. (1993). Psychosocial intervention in cancer. Journal of the National Cancer Institute, 85, 1198–1205.
Spiegel, D., Bloom, J.R. & Yalom, I. (1981). Group support for patients with metastatic cancer: A randomized prospective outcome study. Archives of General Psychiatry, 38, 527–533.
Spiegel, D. & Giese-Davis, J. (2003). Depression and cancer: Mechanisms and disease progression. Biological Psychiatry, 54, 269–282.
Spitzer, R.L., Williams, J.B.W., Gibbon, M. & First, M.B. (1990). Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press.
Stommel, M., Kurtz, M.E., Kurtz, J.C., et al. (2004). A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychology, 23, 564–573.
Suarez-Almazor, M.E., Newman, C., Hanson, J., et al. (2002). Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: Predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. Journal of Clinical Oncology, 20, 2134–2141.
Van der Lee, M.L., van der Bom, J.G., Swarte, N.B., et al. (2005). Euthanasia and depression: A prospective cohort study among terminally ill cancer patients. Journal of Clinical Oncology, 23, 6607–6612.
Van Heeringen, K. & Zivkov, M. (1996). Pharmacological treatment of depression in cancer patients: A placebo-controlled study of Mianserin. British Journal of Psychiatry, 169, 440–443.
Watson, M., Feldman-Stewart, M.D., Brundage, C., et al. (2005). A conceptual framework for patient-professional communication: An application to the cancer context. Psycho-oncology, 14, 801–809.
Watson, M., Haviland, J.S., Greer, S., et al. (1999). Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet, 354, 1331–1336.
Weitzner, M.A., Meyers, C.A., Stuebing, K.K., et al. (1997). Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy. Supportive Care in Cancer, 5, 241–248.
Weitzner, M.A., Moncello, J., Jacobsen, P.B., et al. (2002). A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. Journal of Pain and Symptom Management, 23, 337–345.
Werth, J.L. Jr., Gordon, J.R. & Johnson, R.R. Jr. (2002). Psychosocial issues near the end of life. Aging & Mental Health, 6, 402–412.
Williams, S. & Dale, J. (2006). The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. British Journal of Cancer, 94, 372–390.
Winzelberg, A.J., Classen, C., Alpers, G.W., et al. (2003). Evaluation of an internet support group for women with primary breast cancer. Cancer, 97, 1164–1173.
Wong-Kim, E.C. & Bloom, J.R. (2005). Depression experienced by young women newly diagnosed with breast cancer. Psycho-oncology, 14, 564–573.
Zigmond, A.S. & Snaith, R.P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361–370.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Palliative & Supportive Care
  • ISSN: 1478-9515
  • EISSN: 1478-9523
  • URL: /core/journals/palliative-and-supportive-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *

CAPTCHA *

Skip to the audio challenge
×

Keywords:

Metrics

Full text views

Total number of HTML views: 6
Total number of PDF views: 57 *
Loading metrics...

Abstract views

Total abstract views: 491 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 13th June 2018. This data will be updated every 24 hours.

Cancel
Confirm
×